Prevest Denpro Board Meeting for Q2 FY27 Results

The Board of Directors will consider and approve:

1. The Unaudited Standalone Financial Results of the Company for the quarter and half year ended September 30, 2026

2. The Unaudited Consolidated Financial Results of the Company for the quarter and half year ended September 30, 2026

3. The Interim Dividend for the half year ended September 30, 2026